Clinical Impressions and Therapy Goals

Video content above is prompted by the following:

Describe the case and your initial impressions:

• What would be the predominant goals of therapy for a patient such as this?
• In patients with extensive stage small cell lung cancer (ES-SCLC) that has progressed, how do you balance the survival benefits afforded by subsequent lines of therapy with risks of treatment-related adverse events after progression of disease on platinum-based primary therapy?
• For primary therapy of ES-SCLC, under what circumstances would you consider extending the cycles of chemoimmunotherapy from 4 to 6?